Clinical trial
Evaluation of the Efficacy of Preimplantation Genetic Screening (PGS) in Predicting Embryonic Ploidy and Subsequent Pregnancy Outcomes in in Vitro Fertilization (IVF) Cycles
NCT03604107 is registered in ClinicalTrials.gov with Reproductive Medicine Associates of New Jersey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy of Preimplantation Genetic Screening (PGS) in Predicting Embryonic Ploidy and Subsequent Pregnancy Outcomes in in Vitro Fertilization (IVF) Cycles
- Lead sponsor
- Reproductive Medicine Associates of New Jersey
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 30, 2018
- Completion date
- December 1, 2020
- Enrollment
- 237 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.